Siemens Unveils New Enhancements to its Revenue Cycle Solution Soarian Financials at HIMSS 2009
Workflow-driven solution helps providers streamline revenue cycle management, maximize revenue realization, and supports provider initiatives to enhance the patient experience
CHICAGO, April 4 /PRNewswire-FirstCall/ -- Siemens ( www.siemens.com/healthcare ) today announced enhancemen...
Solos Endoscopy, Inc. Posts First Nine Months Financials for 2008 on Pinksheets.com
BOSTON, Feb. 11 /PRNewswire-FirstCall/ -- Solos Endoscopy, Inc. (Pink Sheets: SNDY) is pleased to announce that the Company has posted its financials
through the first nine months of 2008 on Pinksheets.com for the period ending September 30, 2008. Revenues generated through the nine-months of 2008...
Solos Endoscopy, Inc. Posts First Six Months Financials of 2008 on Pinksheets.com
BOSTON, Oct. 8 /PRNewswire-FirstCall/ -- Solos Endoscopy, Inc. (OTCPK:
SNDY) is pleased to announce that the Company has posted its six-month
financials on Pinksheets.com for the period ending June 30, 2008. Revenues
generated through the first six-months of 2008 amounted to $204,103,
Phyhealth Files Historical Financials With the Pink Sheets and Takes Next Step Toward Becoming Fully Reporting
MIAMI, April 16 /PRNewswire-FirstCall/ -- Physicians Healthcare
Management Group, Inc. (Phyhealth) (Pink Sheets: PHYH), a developer of
health maintenance organizations (HMOs) in partnership with physicians,
today announced that it has filed with the Pink Sheets its audited
financials for the p...
RxElite Announces 3rd Quarter Financials Conference Call
MERIDIAN, Idaho, Nov. 20 /PRNewswire-FirstCall/ -- RxElite Holdings,
Inc., (OTC Bulletin Board: RXEI) a developer, manufacturer, and marketer of
specialty generic prescription drug products will hold a conference call to
review its financial results for the third quarter ended September 30,
American Scientific Resources, Inc. Discloses Reviewed Financials
Company Q1 2008 reviewed financials
available on Pinksheets.com
WESTON, Fla., June 23 /PRNewswire-FirstCall/ -- American Scientific
Resources, Inc. ( http://www.americansci.com/ ) (Pink Sheets: ASFX) is
pleased to announce that its reviewed Q1 2008 financials
are now available
Hard To Treat Diseases (HTDS) Chile Flu Vaccine Tender
... avoid any confusion, due to the fact that there are multiple pending tenders in Chile.
In other Company news, the company intends to release its Q2 financials
on or before August 15th due date, shortly followed by its IP position developments, and some positive strides made in that regard. The documents are ...
Hillenbrand Announces Third-Quarter Earnings Release Date and Conference Call
...Inc. (NYSE: HI ) will announce its third-quarter earnings results before the market opens Wednesday, Aug. 12, 2009. The full text of the release and financials
will be available on the company's Web site at www.HillenbrandInc.com .
The company will hold a conference call and simultaneous webcast wit...
Immucor Announces Fiscal Fourth Quarter Results
... Cash flow from operations for the year ended May 31, 2009 was $79.8 million, compared with $75.1 million in the prior year.
The current year financials
included 10 months of results for BioArray.
"For fiscal 2009, we achieved record revenue, earnings and cash flow from operations," stat...
Hard to Treat Diseases, Inc. (HTDS) Reports on Ribavirin Research as Potential Treatment for MS
...esearch contributions have the potential to transform into enormous and massive gains for HTDS and its shareholders. We expect to be releasing HTDS Q2 financials
shortly, and some positive updates on the IP issue very shortly. (see press release July 9, 2009 /PRNewswire-FirstCall via COMTEX/ for further details...
financials in Medical Technology
financials in Biological Technology
Adolor Corporation to Host Investor Conference Call to Report 2008 Financials and Provide an Update on the Launch of ENTEREG(R) (alvimopan)
- Conference Call Scheduled for February 25, 2009, 5:00 p.m. U.S. ET -
EXTON, Pa., Feb. 18 /PRNewswire-FirstCall/ -- Adolor Corporation (Nasdaq: ADLR ) today announced that it will hold a conference call at 5:00 p.m. ET on Wednesday, February 25, 2009 to discuss fourth quarter and year...
VaxGen Files First Quarter 2007 Financials
SOUTH SAN FRANCISCO, Calif., Sept. 21 /PRNewswire-FirstCall/ -- VaxGen,
Inc. (Pink Sheets: VXGN) announced today that it has filed with the
Securities and Exchange Commission (SEC) its Quarterly Report on Form 10-Q
for the quarter ended March 31, 2007. The report can be found at the link
WARF honored nationally; Wingra Technologies aquired; Third Wave financials up
In this week's Tech Update, by WTN's Mike Klein: The Wisconsin Alumni Research Foundation will receive a medal of honor from the president for its contributions to technology transfer. Wingra Technologies has been acquired by a west-coast software firm. And biotech company Third Wave Technolog...
Transition continues to impact Third Wave financials
Madison, Wis. -- Third Wave Technologies , a provider of molecular diagnostics solutions, reported losses in the second quarter in line with market expectations.
Third Wave reported total revenue of $5.8 million and a net loss of $5.5 million, or 13 cents per diluted share, for the quarter en...
Viral Genetics Creates Subsidiary to Develop Cancer Therapy
... strengthen its place in the marketplace by filing an unaudited financial statement at www.Pink S heets.com . That statement covers the company's financials
for the last 18-months through March 31, 2009. Viral Genetics also recently retired a significant portion of its debt, enabling the majority of any ne...
University of Florida Shands Cancer Center Selects OnCore(r) to Support its Collaborative Research Goals
Protocol & Subject Life Cycle Management Subject Safety Management Protocol & Subject Calendar Management Study financials
Management Electronic Data Capture and Data Management Paperless Committee Management with ePRMS Study Information Portal Custom Reportin...
Sangamo BioSciences Reports Fourth Quarter and Full Year 2008 Financial Results
...Present and publish data from research collaborations in plant agriculture, transgenic animal production and cell-line engineering.
Maintain year-end 2009 cash and investments balance of at least $45.0 million.
Interim Report for the Period 1 January - 30 September 2008 (Unaudited)
...24.2 million in the first nine months
of 2008 compared to DKK 59.7 million in the same period of 2007, which is in
line with expectations.
Net financial income totaled DKK 7.8 million in the first nine months of
2008 compared to DKK 4.9 million in the same period of 2007. Financia...
Standard & Poor's Announces Changes to U.S. Indices
... S&P 500 INDEX - November 12, 2008 COMPANY GICS ECONOMIC SECTOR GICS SUB-INDUSTRY DELETED General Growth financials
Retail REITs Properties
S&P 500 INDEX - November 14, 2008 COMPANY GICS ECONOMIC SECT...
Pharmacyclics Reports First Quarter Fiscal 2009 Financial Results
...n to publicly update any forward-looking statement, whether as a
result of new information, future events or otherwise.
Pharmacyclics, Inc. (a development stage enterprise) Cond...
financials in Biological Dictionary
... of 25-mer oligo ... Affymetrix . Data Processing & Analysis Info (FHCRC campus access only) ... Affymetrix , Inc. (NASDAQ (GS):AFFX) Company financials
Income Statement Balance Sheet Cash Flow Statement Contact Information Affymetrix , Inc Since then, Affymetrix GeneChip® technology has become t...